drugset / Trial / NCT06402955
Imaging Depression in Parkinson's Disease
Phase 2
Recruiting
120 enrolled
Yale University
National Institute of Neurological Disorders and Stroke (NINDS) · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this observational study is to identify targetable neural substrates of depression in Parkinson's Disease for the first time in people with Parkinson's between the ages of 40 and 80, who are experiencing symptoms of depression.
Timeline
- Start
- 2024-09-01
- Primary completion
- 2029-01-01
- Completion
- 2029-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | — | — |